Target Germany! An Integrated Investment Opportunity in Europe’s Leading Cannabis Market
Fully operational, revenue-generating German cannabis group offers an ideal investment opportunity for firms seeking strategic entry, expansion, or synergy within the regulated cannabis, CBD, and industrial hemp markets across Germany and Europe
Listing ID:
29645817710
Licence(s) Held:
German importer/wholesaler (GDP license) and manufacturer (GMP license) of medical cannabis
Seeking €3.9 – €4.2 million investment
Listing Details:
This is a fully operational, revenue-generating cannabis group with integrated operations across both medical cannabis/CBD and industrial hemp verticals.
It is a publicly listed European holding company offering comprehensive exposure to the entire cannabis and industrial hemp value chain.
Backed by a visionary founder-led team with over 100 years of cumulative industry experience, proprietary technology, and strategic partnerships, it offers diversified revenue streams.
The company generated €16 million in 2024, is on track to generate €26 million in revenue for 2025, has a clear path to positive EBITDA by Q1/Q2 2026, with projected revenue of €47 million by 2027.
Healthy gross margins of approximately 32% are projected from 2025–2029.
This integrated powerhouse delivers high-margin, scalable solutions across the entire cannabis and industrial hemp value chains, positioning itself as a leader in the European market.
It provides direct, de-risked access to the rapidly expanding European cannabis market, positioning investors to capitalize on the upcoming EU medical cannabis expansion cycle.
Strategic synergies span several verticals, including Pharmaceutical Distribution (EU-GMP supply chains), Cannabinoid Manufacturing (EU GMP/GDP-compliant production), Product Innovation, Proprietary Technology (patented purification methods), and High-Growth Industrial Hemp Applications (cultivation, extraction, food and feed ingredients, and Novel Food registration pathways).
The company also boasts Digital Health Enablement, with a robust online ecosystem connecting medical cannabis patients, pharmacies, and healthcare professionals, laying the foundation for telehealth and digital prescriptions.
It offers a complete turnkey solution for access to the German and broader European market, with integrated EU operations and global import/export capabilities.
This investment opportunity is ideal for investment firms, public market consolidators, healthcare and pharma companies, cannabis businesses, and food & wellness brands seeking strategic entry, expansion, or synergy within the German and European regulated cannabis, CBD, and industrial hemp markets.
29645817710
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
45958479515
Profitable, GACP-Certified 3,500 ft² micro cultivator in Montreal, QC for $599k obo
Exceptional opportunity to acquire an operational, GACP-certified, 3,500 ft² licensed micro-cultivation located in a multi-unit industrial complex located in Montreal, QC, featuring significant profit potential
37240564521
Profitable, high-growth telemedicine platform serving the German medical cannabis market
Unique opportunity to acquire a rapidly scaling, fully remote telemedicine and digital prescription, GDPR-compliant platform operating under the EU cross-border framework. The business connects over 20,000 patients with licensed doctors and pharmacies in Germany
43087719945
Turnkey, GPP-Compliant micro-processing facility with rec sales in Toronto for $500k OBO
Unique opportunity to acquire a fully turnkey, leased, GPP-compliant licensed processing facility centrally 30 mins north of Toronto. Features a recreational sales license for both flower and extracts with significant on-site expansion potential